Contract A208_P4820156

Virginia Polytechnic Institute and State University awarded a contract to Revvity Health Sciences Inc. on August 4, 2026, with a cumulative value of $2,696.96. The contract involves the procurement of two specialized radiopharmaceutical products for delivery to Taylor Monica at a Virginia location. The products include BLU507H250UC-UTP, a uridine triphosphate (UTP) labeled with phosphorus-32 at 3000 Curies per millimole concentration with 10 millicuries per milliliter activity, and BLU002H250UC-ATP, an adenosine triphosphate (ATP) similarly labeled with phosphorus-32 at 3000 Curies per millimole concentration with 5 millicuries per milliliter activity.

The contract line items specify unit prices of $1,821.82 for the BLU507H250UC-UTP product and $875.14 for the BLU002H250UC-ATP product, with one unit of each item ordered. These radiopharmaceutical materials are typically utilized in research applications, diagnostics, or laboratory procedures at academic and research institutions. No specific contract period of performance or annual value allocation is provided in the available documentation. The procurement was executed by Virginia Polytechnic Institute and State University, suggesting the materials are intended for institutional research or educational purposes.